Pfizer Inc. (PFE) — Fair Value Analysis

Base-case fair value (P50): $24.15 · Current price: $26.79 · Verdict: Fairly Valued

The Verdict on PFE

Pfizer (PFE) is currently deemed Fairly Valued based on our proprietary Monte Carlo simulations, which model thousands of future scenarios to establish a probabilistic fair value range. The analytical framework, incorporating various growth, margin, and discount rate possibilities, suggests PFE's valuation is largely in line with its fundamental outlook. While the current market price of $26.79 sits marginally above our median fair value (P50) of $24.15, the implied -9.9% indicates that PFE is trading within a reasonable band, reflecting a balanced risk-reward profile as per our current models. This neutral stance suggests that significant undervaluation or overvaluation is not immediately apparent through this analytical lens.

How PFE stacks up against Healthcare

Within the Healthcare sector, Pfizer's operational and financial health is currently categorized as weak. This quality tier assessment reflects existing challenges and ongoing pressures, placing the company's valuation of $26.79 into a broader sector context. While our Monte Carlo simulations render a Fairly Valued verdict, the persistent weak quality tier suggests PFE may face more significant headwinds or possess lower resilience compared to its sector peers. Investors should carefully consider the implications of this quality standing when evaluating the -9.9% indicated by our P50 fair value of $24.15, as it highlights the company's relative position within the competitive Healthcare landscape.

What this means for investors

For investors, the Fairly Valued assessment means PFE's stock price of $26.79 appears to largely discount its known fundamentals, including the challenges implied by its weak quality tier. While the Monte Carlo P50 fair value of $24.15 indicates a -9.9% gap, this range suggests a balanced risk-reward profile without significant undervaluation or overvaluation. Given the weak quality tier, any potential upside should be viewed with a nuanced understanding of the company's operational and financial position. Sign up for a free FairCurve account to see the complete bear and bull case distribution and track PFE's fair value as new fundamentals are released.